Skip to Main ContentSkip to FooterSkip to Search
  1. Home
  2.  » 
  3. Expert Content
  4.  » 
  5. Gene Therapy
  6.  » UpTempo Virtuoso™ AAV Platform Process

UpTempo Virtuoso™ AAV Platform Process

Summary: Catalent’s UpTempo Virtuoso™ AAV platform process is a scalable, CGMP-ready process for viral vector manufacturing that can reduce the current 18-20-month development timeline for drug product in half.

 

Click here to download the Fact Sheet